The Heparin Binding Properties of Heparin Cofactor II Suggest an Antithrombin-like Activation Mechanism
Open Access
- 1 November 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (48) , 50267-50273
- https://doi.org/10.1074/jbc.m408774200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Heparin Cofactor II Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly IndividualsCirculation, 2004
- High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary InterventionCirculation, 2004
- Targeting thrombin – rational drug design from natural mechanismsTrends in Pharmacological Sciences, 2003
- Heparin Cofactor II DeficiencyArchives of Pathology & Laboratory Medicine, 2002
- Heparin cofactor II inhibits arterial thrombosis after endothelial injuryJournal of Clinical Investigation, 2002
- Platelet Aggregation Induced In Vitro by Rabbit Plasma Clot-associated Thrombin, and Its Inhibition by Thrombin InhibitorsThrombosis and Haemostasis, 1998
- A player of many parts: The spotlight falls on thrombin's structureThrombosis Research, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor IIBiochimica et Biophysica Acta (BBA) - General Subjects, 1988
- Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharidesBritish Journal of Haematology, 1986